High-Throughput Bacteriophage Testing with Potency Determination: Validation of an Automated Pipetting and Phage Drop-Off Method

Author:

Dufour Nicolas123ORCID,Delattre Raphaëlle234ORCID,Debarbieux Laurent2ORCID

Affiliation:

1. Réanimation Médico-Chirurgicale, Hôpital NOVO—Site de Pontoise, 95300 Pontoise, France

2. Institut Pasteur, Université Paris Cité, CNRS UMR6047, Bacteriophage Bacterium Host, 75015 Paris, France

3. IAME, Université de Paris, INSERM U1137, Université Sorbonne Paris Nord, 75018 Paris, France

4. Réanimation, Centre Hospitalier de Digne-les-Bains, 04000 Digne-les-Bains, France

Abstract

The development of bacteriophages (phages) as active pharmaceutical ingredients for the treatment of patients is on its way and regulatory agencies are calling for reliable methods to assess phage potency. As the number of phage banks is increasing, so is the number of phages that need to be tested to identify therapeutic candidates. Currently, assessment of phage potency on a semi-solid medium to observe plaque-forming units is unavoidable and proves to be labor intensive when considering dozens of phage candidates. Here, we present a method based on automated pipetting and phage drop-off performed by a liquid-handling robot, allowing high-throughput testing and phage potency determination (based on phage titer and efficiency of plaquing). Ten phages were tested, individually and assembled into one cocktail, against 126 Escherichia coli strains. This automated method was compared to the reference one (manual assay) and validated in terms of reproducibility and concordance (ratio of results according to the Bland and Altman method: 0.99; Lin’s concordance correlation coefficient: 0.86). We found that coefficients of variation were lower with automated pipetting (mean CV: 13.3% vs. 24.5%). Beyond speeding up the process of phage screening, this method could be used to standardize phage potency evaluation.

Funder

AP-HP / Institut Pasteur

Agence Nationale de la Recherche

Publisher

MDPI AG

Reference32 articles.

1. European Directorate for the Quality of Medicines & HealthCare (2023, November 12). Public Consultation on New General Chapter on Phage Therapy Active Substances and Medicinal Products for Human and Veterinary Use in Pharmeuropa 35.2. Available online: https://www.edqm.eu/en/home/-/asset_publisher/wQkauHDDLDSk/content/public-consultation-on-new-general-chapter-on-phage-therapy-active-substances-and-medicinal-products-for-human-and-veterinary-use-in-pharmeuropa-35.2.

2. Adaptive Phage Therapeutics (2023, November 12). Adaptive Phage Therapeutics Announces FDA Clearance of IND Application for APT’s Phage Bank for the Treatment of Prosthetic Joint Infections. Available online: https://aphage.com/adaptive-phage-therapeutics-announces-fda-clearance-of-ind-application-for-phagebank-for-the-treatment-of-prosthetic-joint-infections/.

3. The phage therapy paradigm: Pret-a-porter or sur-mesure?;Pirnay;Pharm. Res.,2011

4. Phage Biobank: Present Challenges and Future Perspectives;Lin;Curr. Opin. Biotechnol.,2021

5. Yerushalmy, O., Khalifa, L., Gold, N., Rakov, C., Alkalay-Oren, S., Adler, K., and Hazan, R. (2020). The Israeli Phage Bank (IPB). Antibiotics, 9.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3